Fig. 2From: Prolonged postoperative length of stay may be a valuable marker for susceptibility to relapse beyond established risk factors in patients with stage III colon cancerDisease-free survival among the three length of stay groups, presented with two survival plots: one cohort who received adjuvant chemotherapy and one who failed to receive adjuvant chemotherapyBack to article page